Join
Live feed
·
PRReleasevia Quantisnow
BriaCell Therapeutics Corp. logo

BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients

ByQuantisnow·Wall Street's wire, on your screen.
BCTX· BriaCell Therapeutics Corp.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BCTX (BriaCell Therapeutics Corp.) and more on Quantisnow.